Scaling and interpreting treatment effects in clinical trials using restricted mean survival time.
Theodore G KarrisonChen HuJames DignamPublished in: Clinical trials (London, England) (2024)
In addition to the difference in restricted mean survival times, these alternative measures can be helpful in determining whether the magnitude of the treatment effect is clinically meaningful.